Ch. Schnack

648 total citations
20 papers, 500 citations indexed

About

Ch. Schnack is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ch. Schnack has authored 20 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Nephrology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ch. Schnack's work include Chronic Kidney Disease and Diabetes (6 papers), Blood Pressure and Hypertension Studies (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Ch. Schnack is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Blood Pressure and Hypertension Studies (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Ch. Schnack collaborates with scholars based in Austria, Germany and United States. Ch. Schnack's co-authors include Guntram Schernthaner, G. Schernthaner, Rudolf Prager, Hans‐Georg Kopp, Peter Pietschmann, P. Hopmeier, F. Mittermayer, Katarzyna Krzyżanowska, Paul Knöbl and Mathias Müller and has published in prestigious journals such as Hypertension, Diabetologia and Journal of Clinical Pathology.

In The Last Decade

Ch. Schnack

20 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ch. Schnack Austria 14 200 154 113 85 68 20 500
Alfredo Quiñones Galvan Italy 11 241 1.2× 179 1.2× 71 0.6× 79 0.9× 25 0.4× 13 455
J. Rosenthal Germany 13 226 1.1× 168 1.1× 46 0.4× 166 2.0× 75 1.1× 38 539
Ryu Kobayashi Japan 15 227 1.1× 162 1.1× 93 0.8× 125 1.5× 44 0.6× 42 521
Giorgia Pierelli Italy 6 145 0.7× 71 0.5× 86 0.8× 156 1.8× 50 0.7× 7 494
Rosalia Arsena Italy 12 193 1.0× 57 0.4× 173 1.5× 40 0.5× 49 0.7× 17 504
Raffaella Riccobene Italy 10 253 1.3× 64 0.4× 221 2.0× 48 0.6× 66 1.0× 13 528
Henry Yu United States 6 259 1.3× 111 0.7× 64 0.6× 54 0.6× 38 0.6× 8 478
Anna Vadalà Italy 14 240 1.2× 45 0.3× 159 1.4× 42 0.5× 60 0.9× 17 478
Lasse Bent-Hansen Denmark 10 112 0.6× 150 1.0× 120 1.1× 62 0.7× 57 0.8× 15 381
Silvia Mennuni Italy 5 139 0.7× 63 0.4× 83 0.7× 117 1.4× 41 0.6× 7 406

Countries citing papers authored by Ch. Schnack

Since Specialization
Citations

This map shows the geographic impact of Ch. Schnack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch. Schnack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch. Schnack more than expected).

Fields of papers citing papers by Ch. Schnack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ch. Schnack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch. Schnack. The network helps show where Ch. Schnack may publish in the future.

Co-authorship network of co-authors of Ch. Schnack

This figure shows the co-authorship network connecting the top 25 collaborators of Ch. Schnack. A scholar is included among the top collaborators of Ch. Schnack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ch. Schnack. Ch. Schnack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schnack, Ch. & G. Schernthaner. (2009). Pituitary Thyrotroph Function and Thyroid Hormones in Longstanding Type-II Diabetes Mellitus before and after Insulin Treatment. Experimental and Clinical Endocrinology & Diabetes. 90(5). 243–248. 1 indexed citations
2.
Krzyżanowska, Katarzyna, Laura Zemany, Walter Krugluger, et al.. (2008). Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia. 51(7). 1115–1122. 72 indexed citations
3.
Krzyżanowska, Katarzyna, F. Mittermayer, Ch. Schnack, et al.. (2005). Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency. European Journal of Clinical Investigation. 35(3). 208–213. 18 indexed citations
4.
Krzyżanowska, Katarzyna, Ch. Schnack, F. Mittermayer, et al.. (2005). High Prevalence of Abnormal Circadian Blood Pressure Regulation and Impaired Glucose Tolerance in Adults with Hypopituitarism. Experimental and Clinical Endocrinology & Diabetes. 113(8). 430–434. 10 indexed citations
5.
Eibl, N, Ch. Schnack, M Frank, & G. Schernthaner. (1998). Initial urinary albumin excretion determines the progression of microalbuminuria in patients with type-2 diabetes and normotensive blood pressure values despite improved metabolic control. Diabetes Research and Clinical Practice. 39(1). 39–45. 3 indexed citations
6.
Schnack, Ch., et al.. (1996). Nondipping of Nocturnal Blood Pressure Is Related to Urinary Albumin Excretion Rate in Patients With Type 2 Diabetes Mellitus. American Journal of Hypertension. 9(11). 1139–1143. 64 indexed citations
7.
8.
Schnack, Ch., Walter Hoffmann, P. Hopmeier, & Guntram Schernthaner. (1996). Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria. Diabetologia. 39(12). 1611–1616. 19 indexed citations
9.
10.
Schnack, Ch., et al.. (1994). Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study. Journal of Molecular Medicine. 72(12). 961–966. 16 indexed citations
11.
Knöbl, Paul, Peter Pietschmann, Ch. Schnack, Rudolf Prager, & G. Schernthaner. (1994). Apolipoprotein (a) levels in patients with type 1 diabetes mellitus are unrelated to metabolic control or vascular disease.. PubMed. 106(23). 728–32. 3 indexed citations
12.
Knöbl, Paul, G. Schernthaner, Ch. Schnack, et al.. (1993). Thrombogenic factors are related to urinary albumin excretion rate in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 36(10). 1045–1050. 71 indexed citations
13.
Watschinger, Bruno, et al.. (1993). Left Ventricular Diastolic Impairment in Type 1 Diabetic Patients with Microalbuminuria. ˜The œNephron journals/Nephron journals. 63(2). 145–151. 21 indexed citations
14.
15.
Schernthaner, G., et al.. (1991). Vermindertes Plasmacarnitin bei Typ-I Diabetes mellitus. Journal of Molecular Medicine. 69(12). 511–516. 13 indexed citations
16.
Haber, Penina, et al.. (1991). [Effect of structured ambulatory training of patients with chronic respiratory tract diseases on the efficiency of long-term care].. PubMed. 103(20). 605–11. 2 indexed citations
17.
Klauser, Renate, et al.. (1991). Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus.. Hypertension. 17(1). 15–21. 39 indexed citations
18.
Pietschmann, Peter, et al.. (1988). Serum concentrations of laminin P1 in diabetics with advanced nephropathy.. Journal of Clinical Pathology. 41(9). 929–932. 16 indexed citations
19.
20.
Schnack, Ch., et al.. (1986). Effects of the?-glucosidase inhibitor 1 desoxynojirimycin (BAY M 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients. European Journal of Clinical Pharmacology. 30(4). 417–419. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfredo Quiñones Galvan Breakdown of academic impact, for papers by J. Rosenthal Breakdown of academic impact, for papers by Ryu Kobayashi Breakdown of academic impact, for papers by Giorgia Pierelli Breakdown of academic impact, for papers by Rosalia Arsena Breakdown of academic impact, for papers by Raffaella Riccobene Breakdown of academic impact, for papers by Henry Yu Breakdown of academic impact, for papers by Anna Vadalà Breakdown of academic impact, for papers by Lasse Bent-Hansen Breakdown of academic impact, for papers by Silvia Mennuni
Rankless by CCL
2026